QIAGEN N.V.
QGEN
$45.42
-$0.18-0.40%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.49% | 5.37% | 2.36% | 5.46% | 0.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.49% | 5.37% | 2.36% | 5.46% | 0.30% |
| Cost of Revenue | -58.34% | 5.43% | -3.35% | 5.79% | 167.87% |
| Gross Profit | 595.51% | 5.35% | 5.41% | 5.29% | -84.77% |
| SG&A Expenses | 3.80% | -0.54% | -2.91% | 0.39% | -1.52% |
| Depreciation & Amortization | -15.65% | -18.73% | -18.23% | -14.31% | -4.50% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.46% | -0.99% | -2.82% | 1.02% | 72.44% |
| Operating Income | 184.79% | 28.74% | 18.92% | 20.73% | -240.62% |
| Income Before Tax | 156.76% | 16.87% | 5.87% | 16.65% | -318.39% |
| Income Tax Expenses | 176.44% | 33.19% | 76.93% | -16.41% | -285.75% |
| Earnings from Continuing Operations | 152.46% | 12.50% | -9.57% | 26.01% | -327.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 152.46% | 12.50% | -9.57% | 26.01% | -327.09% |
| EBIT | 184.79% | 28.74% | 18.92% | 20.73% | -240.62% |
| EBITDA | 273.38% | 11.67% | 9.71% | 13.72% | -164.76% |
| EPS Basic | 152.26% | 12.11% | -9.74% | 25.50% | -326.36% |
| Normalized Basic EPS | 190.33% | 25.72% | 14.51% | 21.29% | -239.63% |
| EPS Diluted | 151.54% | 10.72% | -9.77% | 25.55% | -330.05% |
| Normalized Diluted EPS | 189.71% | 26.20% | 14.51% | 21.60% | -241.08% |
| Average Basic Shares Outstanding | 0.41% | 0.35% | 0.19% | 0.41% | 0.30% |
| Average Diluted Shares Outstanding | 1.09% | -0.04% | 0.19% | 0.15% | -0.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |